Warning! GuruFocus detected
4 Severe warning signs
with 76D.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Medesis Pharma SA
ISIN : FR0010844464
Share Class Description:
STU:76D: Ordinary SharesCompare
Compare
Traded in other countries / regions
ALMDP.France76D.Germany IPO Date
2022-02-07Description
Medesis Pharma SA is a clinical development stage biopharmaceutical company. It is engaged in the development of orally administered molecule drug candidates to expand therapeutic usefulness to address major unmet medical needs.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.01 | |||||
| Equity-to-Asset | -2.42 | |||||
| Debt-to-Equity | -0.42 | |||||
| Debt-to-EBITDA | -0.68 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -24.14 | |||||
| Beneish M-Score | -6.5 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6.3 | |||||
| 3-Year EBITDA Growth Rate | -54.5 | |||||
| 3-Year EPS without NRI Growth Rate | -58.3 | |||||
| 3-Year Book Growth Rate | -22.5 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 25.3 | |||||
| 9-Day RSI | 35.3 | |||||
| 14-Day RSI | 40.18 | |||||
| 3-1 Month Momentum % | 18.75 | |||||
| 6-1 Month Momentum % | -22.27 | |||||
| 12-1 Month Momentum % | -76.41 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.35 | |||||
| Quick Ratio | 0.31 | |||||
| Days Inventory | 27.62 | |||||
| Days Payable | 237.67 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5.6 | |||||
| Shareholder Yield % | 39.98 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -3277.78 | |||||
| Operating Margin % | -5606.35 | |||||
| Net Margin % | -4974.6 | |||||
| ROA % | -163.37 | |||||
| ROIC % | -407.98 | |||||
| 3-Year ROIIC % | -2019.73 | |||||
| ROC (Joel Greenblatt) % | -2607.81 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 0.16 | |||||
| PS Ratio | 29.17 | |||||
| EV-to-EBIT | -0.83 | |||||
| EV-to-EBITDA | -0.9 | |||||
| EV-to-Revenue | 45.35 | |||||
| Price-to-GF-Value | 0.04 | |||||
| Earnings Yield (Greenblatt) % | -120.48 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medesis Pharma SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.063 | ||
| EPS (TTM) (€) | -0.626 | ||
| Beta | 0.77 | ||
| 3-Year Sharpe Ratio | -0.79 | ||
| 3-Year Sortino Ratio | -0.98 | ||
| Volatility % | 76.51 | ||
| 14-Day RSI | 40.18 | ||
| 14-Day ATR (€) | 0.00851 | ||
| 20-Day SMA (€) | 0.29835 | ||
| 12-1 Month Momentum % | -76.41 | ||
| 52-Week Range (€) | 0.24 - 1.505 | ||
| Shares Outstanding (Mil) | 5.15 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medesis Pharma SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medesis Pharma SA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Medesis Pharma SA Frequently Asked Questions
What is Medesis Pharma SA(STU:76D)'s stock price today?
The current price of STU:76D is €0.29. The 52 week high of STU:76D is €1.51 and 52 week low is €0.24.
When is next earnings date of Medesis Pharma SA(STU:76D)?
The next earnings date of Medesis Pharma SA(STU:76D) is .
Does Medesis Pharma SA(STU:76D) pay dividends? If so, how much?
Medesis Pharma SA(STU:76D) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers